Rikova K (2008) CST Curation Set: 5697; Year: 2008; Biosample/Treatment: cell line, H3122 Silac inh2/inhibitor; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Akt Substrate (RXRXXS*/T*) (23C8D2) Rabbit mAb Cat#: 10001, PTMScan(R) Phospho-Akt Substrate Motif (RXRXXS*/T*) Immunoaffinity Beads Cat#: 1979

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

S2328-p - C2CD3 (human) ▲
Modsite: PCRPRPNsLPLNLPE SwissProt Entrez-Gene Orthologous residues C2CD3 (human): S2328‑p, C2CD3 (mouse): S2295‑p, C2CD3 (rat): S2291‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T195-p - CCDC102B (human) ▲
Modsite: LVKRQFStKEDtNNK SwissProt Entrez-Gene Orthologous residues CCDC102B (human): T195‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T199-p - CCDC102B (human) ▲
Modsite: QFStKEDtNNKEQGV SwissProt Entrez-Gene Orthologous residues CCDC102B (human): T199‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1151-p - DISP2 (human) ▲
Modsite: AGRPRPGsVGGMPGS SwissProt Entrez-Gene Orthologous residues DISP2 (human): S1151‑p, DISP2 (mouse): ‑, DISP2 (rat): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry

T533-p - EPC1 (human) ▲
Modsite: WRHFRPRtPsLHDsD SwissProt Entrez-Gene Orthologous residues EPC1 (human): T533‑p, EPC1 (mouse): T532‑p, EPC1 (rat): T532‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S535-p - EPC1 (human) ▲
Modsite: HFRPRtPsLHDsDND SwissProt Entrez-Gene Orthologous residues EPC1 (human): S535‑p, EPC1 (mouse): S534‑p, EPC1 (rat): S534‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S539-p - EPC1 (human) ▲
Modsite: RtPsLHDsDNDELSC SwissProt Entrez-Gene Orthologous residues EPC1 (human): S539‑p, EPC1 (mouse): S538‑p, EPC1 (rat): S538‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T257-p - LARP7 (human) ▲
Modsite: KMKRsRPtsEGsDIE SwissProt Entrez-Gene Orthologous residues LARP7 (human): T257‑p, LARP7 iso2 (human): ‑, LARP7 iso3 (human): T264‑p, LARP7 (mouse): A252‑p, LARP7 (rat): A253‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S258-p - LARP7 (human) ▲
Modsite: MKRsRPtsEGsDIEs SwissProt Entrez-Gene Orthologous residues LARP7 (human): S258‑p, LARP7 iso2 (human): ‑, LARP7 iso3 (human): S265‑p, LARP7 (mouse): S253‑p, LARP7 (rat): S254‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S261-p - LARP7 (human) ▲
Modsite: sRPtsEGsDIEstEP SwissProt Entrez-Gene Orthologous residues LARP7 (human): S261‑p, LARP7 iso2 (human): ‑, LARP7 iso3 (human): S268‑p, LARP7 (mouse): S256‑p, LARP7 (rat): S257‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T905-p - LMO7 (human) ▲
Modsite: RsYRKTDtVRLtsVV SwissProt Entrez-Gene Orthologous residues LMO7 (human): T905‑p, LMO7 iso2 (human): T905‑p, LMO7 iso3 (human): T571‑p, LMO7 iso4 (human): T905‑p, LMO7 (mouse): T900‑p, LMO7 iso4 (mouse): T333‑p, LMO7 (rat): T932‑p, LMO7 iso3 (rat): T598‑p, LMO7 iso4 (rat): T365‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S910-p - LMO7 (human) ▲
Modsite: TDtVRLtsVVtPrPF SwissProt Entrez-Gene Orthologous residues LMO7 (human): S910‑p, LMO7 iso2 (human): S910‑p, LMO7 iso3 (human): S576‑p, LMO7 iso4 (human): S910‑p, LMO7 (mouse): S905‑p, LMO7 iso4 (mouse): S338‑p, LMO7 (rat): S937‑p, LMO7 iso3 (rat): S603‑p, LMO7 iso4 (rat): S370‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T905-p - LMO7 iso2 (human) ▲
Modsite: RSYRKTDtVRLTsVV SwissProt Entrez-Gene Orthologous residues LMO7 (human): T905‑p, LMO7 iso2 (human): T905‑p, LMO7 iso3 (human): T571‑p, LMO7 iso4 (human): T905‑p, LMO7 (mouse): T900‑p, LMO7 iso4 (mouse): T333‑p, LMO7 (rat): T932‑p, LMO7 iso3 (rat): T598‑p, LMO7 iso4 (rat): T365‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S910-p - LMO7 iso2 (human) ▲
Modsite: TDtVRLTsVVtPRPF SwissProt Entrez-Gene Orthologous residues LMO7 (human): S910‑p, LMO7 iso2 (human): S910‑p, LMO7 iso3 (human): S576‑p, LMO7 iso4 (human): S910‑p, LMO7 (mouse): S905‑p, LMO7 iso4 (mouse): S338‑p, LMO7 (rat): S937‑p, LMO7 iso3 (rat): S603‑p, LMO7 iso4 (rat): S370‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T571-p - LMO7 iso3 (human) ▲
Modsite: RSYRKTDtVRLTsVV SwissProt Entrez-Gene Orthologous residues LMO7 (human): T905‑p, LMO7 iso2 (human): T905‑p, LMO7 iso3 (human): T571‑p, LMO7 iso4 (human): T905‑p, LMO7 (mouse): T900‑p, LMO7 iso4 (mouse): T333‑p, LMO7 (rat): T932‑p, LMO7 iso3 (rat): T598‑p, LMO7 iso4 (rat): T365‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S576-p - LMO7 iso3 (human) ▲
Modsite: TDtVRLTsVVtPRPF SwissProt Entrez-Gene Orthologous residues LMO7 (human): S910‑p, LMO7 iso2 (human): S910‑p, LMO7 iso3 (human): S576‑p, LMO7 iso4 (human): S910‑p, LMO7 (mouse): S905‑p, LMO7 iso4 (mouse): S338‑p, LMO7 (rat): S937‑p, LMO7 iso3 (rat): S603‑p, LMO7 iso4 (rat): S370‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T112-p - Pumilio-1 (human) ▲
Modsite: NskHRWPtGDNIHAE SwissProt Entrez-Gene Orthologous residues Pumilio‑1 (human): T112‑p, Pumilio‑1 iso2 (human): T112‑p, Pumilio‑1 iso3 (human): T112‑p, Pumilio‑1 iso4 (human): T148‑p, Pumilio‑1 (mouse): T112‑p, Pumilio‑1 (rat): T112‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S532-p - SARG (human) ▲
Modsite: NSRPRPAsLGTGKDF SwissProt Entrez-Gene Orthologous residues SARG (human): S532‑p, SARG iso2 (human): S286‑p, SARG (mouse): S537‑p, SARG (rat): S535‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T916-p - SETD1A (human) ▲
Modsite: EkRPRPstPAEEDED SwissProt Entrez-Gene Orthologous residues SETD1A (human): T916‑p, SETD1A (mouse): T931‑p, SETD1A (rat): T929‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S245-p - SHISA7 (human) ▲
Modsite: TRPDRARsssLTPGI SwissProt Entrez-Gene Orthologous residues SHISA7 (human): S245‑p, SHISA7 (mouse): S248‑p, SHISA7 iso2 (mouse): S248‑p, SHISA7 (rat): S248‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S246-p - SHISA7 (human) ▲
Modsite: RPDRARsssLTPGIG SwissProt Entrez-Gene Orthologous residues SHISA7 (human): S246‑p, SHISA7 (mouse): S249‑p, SHISA7 iso2 (mouse): S249‑p, SHISA7 (rat): S249‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S295-p - SRm300 (human) ▲
Modsite: ttALAGRsPsPAsGR SwissProt Entrez-Gene Orthologous residues SRm300 (human): S295‑p, SRm300 iso2 (human): S295‑p, SRm300 (mouse): S295‑p, SRm300 iso2 (mouse): S199‑p, SRm300 iso3 (mouse): S295‑p, SRm300 (rat): S295‑p, SRm300 (cow): S295‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S297-p - SRm300 (human) ▲
Modsite: ALAGRsPsPAsGRRG SwissProt Entrez-Gene Orthologous residues SRm300 (human): S297‑p, SRm300 iso2 (human): S297‑p, SRm300 (mouse): P297‑p, SRm300 iso2 (mouse): P201‑p, SRm300 iso3 (mouse): P297‑p, SRm300 (rat): P297‑p, SRm300 (cow): S297‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S75-p - TCF23 (human) ▲
Modsite: GGLALGRsEAsPENA SwissProt Entrez-Gene Orthologous residues TCF23 (human): S75‑p, TCF23 (mouse): S74‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S78-p - TCF23 (human) ▲
Modsite: ALGRsEAsPENAARE SwissProt Entrez-Gene Orthologous residues TCF23 (human): S78‑p, TCF23 (mouse): S77‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S87-p - TCF23 (human) ▲
Modsite: ENAARERsRVRtLRQ SwissProt Entrez-Gene Orthologous residues TCF23 (human): S87‑p, TCF23 (mouse): T86‑p Characterization Methods used to characterize site in vivo:  mass spectrometry